Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 3Sarcoma 2Breast 2Plasma cell 1Other hematologic neoplasm 1

Conditions

Breast Neoplasms 2551Triple Negative Breast Neoplasms 436Carcinoma, Non-Small-Cell Lung 339Ovarian Neoplasms 315Neoplasms 281Neoplasm Metastasis 253Colorectal Neoplasms 246Stomach Neoplasms 202Pancreatic Neoplasms 196Prostatic Neoplasms 188Lung Neoplasms 180Melanoma 171Squamous Cell Carcinoma of Head and Neck 140Endometrial Neoplasms 140Head and Neck Neoplasms 124Carcinoma, Renal Cell 118Uterine Cervical Neoplasms 104Esophageal Neoplasms 97Urinary Bladder Neoplasms 92Small Cell Lung Carcinoma 87Sarcoma 85Colonic Neoplasms 80Carcinoma, Hepatocellular 62Carcinoma, Transitional Cell 61Kidney Neoplasms 51Advanced Breast Cancer 51Cholangiocarcinoma 50Liver Neoplasms 47Brain Neoplasms 43Mesothelioma 37

Interventions

Zoledronic Acid 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Fractures, Bone × Breast × Clear all
NCT00321464 2022-11-08

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.

Amgen

Phase 3 Completed
2,049 enrolled 16 charts
Breast

Breast Neoplasms, Fractures, Bone

NCT00859560 2009-03-11

Retrospective Survey of Bone Fracture in Patients With Arimidex 1mg

AstraZeneca

Completed
2,205 enrolled
Breast

Breast Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡